TD Asset Management
GMED icon

TD Asset Management’s Globus Medical GMED Stock Holding History

TD Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-99,461
Closed -$7.34M – 1481
2022
Q1 		$7.34M Hold
99,461
– – 0.01% 731
2021
Q4 		$7.18M Buy
99,461
+2,372
+2% +$172K 0.01% 765
2021
Q3 		$7.44M Hold
97,089
– – 0.01% 724
2021
Q2 		$8.07M Buy
97,089
+17,987
+23% +$1.28M 0.01% 706
2021
Q1 		$4.88M Buy
79,102
+4,104
+5% +$260K 0.01% 833
2020
Q4 		$4.89M Buy
74,998
+4,371
+6% +$251K 0.01% 792
2020
Q3 		$3.5M Sell
70,627
-194,347
-73% -$10M ﹤0.01% 798
2020
Q2 		$12.6M Buy
264,974
+50,977
+24% +$2.46M 0.02% 458
2020
Q1 		$9.1M Buy
+213,997
New +$10.6M 0.02% 493

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

TD Asset Management's GMED Position: Q2 2022 in Review

TD Asset Management sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 99,461 shares — an estimated $7.34M sold.

TD Asset Management first reported a position in GMED in Q1 2020 and held it in 9 quarters. The position peaked at $12.6M in Q2 2020. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

  • TD Asset Management reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
  • TD Asset Management sold 99,461 Globus Medical shares in Q2 2022, an estimated $7.34M.
  • TD Asset Management first reported a position in Globus Medical in Q1 2020 and held it in 9 quarters.
  • TD Asset Management's Globus Medical position peaked at $12.6M in Q2 2020.
  • 364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on TD Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.